{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/171766827",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/156218529"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#171766827",
  "code": "3B21.1",
  "source": "http://id.who.int/icd/entity/171766827",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Haemorrhage due to factor Xa inhibitor"
  },
  "definition": {
    "@language": "en",
    "@value": "A disease caused by factor Xa inhibitor that affects normal coagulation of the blood. This disease is characterised by inability of the blood to coagulate leading to bleeding. Confirmation is by identification of factor Xa inhibitor in a blood sample."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Haemorrhage due to factor Xa inhibitor"
      }
    }
  ]
}